The Centers for Medicare and Medicaid Services (CMS) recently proposed two major drug pricing models: GLOBE for Medicare Part B and GUARD for Medicare Part D. Together, these policies would introduce significant changes to how drugs are priced, posing serious risks to patients and medical innovation…
Read MoreThe Trade Alliance to Promote Prosperity today wrote to U.S. Secretary of Commerce Howard Lutnick to express the organization's opposition to the Eliminating Thickets to Improve Competition (ETHIC) Act (H.R. 3269, S. 2276), which would undermine the constitutionally guaranteed patent rights that America’s innovators expect and enjoy…
Read MoreThe Trade Alliance to Promote Prosperity applauds bipartisan pharmacy benefit manager (PBM) accountability legislation recently proposed in Congress and is calling for its swift passage…
Read MoreThe Trade Alliance to Promote Prosperity is calling on Congress to stop letting the world freeload off American patients. On a global scale, the United States has a bunch of freeloading friends when it comes to paying for prescription drugs. Foreign governments routinely enforce low drug prices in their countries, while expecting U.S. patients and taxpayers to underwrite the costs of research, development, and commercialization…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., recently had an op-ed, "Toward a global alliance for fair drug pricing and innovation," published in the Odessa, Texas, American newspaper…
Read MoreThe Trade Alliance to Promote Prosperity recently signed onto a conservative coalition letter supporting the U.S. Patent and Trademark Office’s recent Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Board’s (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025).
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., has a column in the DC Journal today, titled "Crackdown on Transshipping Is Critically Needed,” commending the Trump administration for its efforts to curb tariff evasion…
Read MoreThe Trade Alliance to Promote Prosperity has joined a coalition of over two dozen conservative organizations in signing a letter to President Trump, opposing a regulatory change proposed by the United Kingdom Intellectual Property Office (UK IPO). If adopted, the UK IPO’s provisions would significantly threaten U.S. leadership in critical technologies—including artificial intelligence and 6G wireless—in which standardization is central…
Read MoreOctober is Intellectual Property (IP) Awareness Month, marking a crucial time to recognize the vital role that IP plays in driving innovation, strengthening the economy, and protecting creators’ rights…
Read MoreThe Congressional Budget Office (CBO) recently released a report examining the 340B Drug Pricing Program—a program originally designed to help low-income and vulnerable patients gain access to affordable medicines. The findings raise troubling questions about whether the program is delivering on its promise…
Read MoreRecently, drug manufacturer Pfizer and the Trump Administration announced a deal aimed at lowering prescription drug costs for Americans…
Read MorePresident Trump’s administration is rolling out a questionable new tariff policy: 100% tariffs on pharmaceuticals made outside the United States. The ostensible goal is to deliver more domestic manufacturing, but instead, it creates real risks for patients, affordability, and access to care…
Read MoreThe Trade Alliance to Promote Prosperity recently joined a coalition of 20+ organizations in signing onto a letter to President Trump and Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., opposing potential price control measures included in the administration’s Most Favored Nation plan…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., has a column published in the DC Journal today, "AI Action Plan Sets the Right Course," which discusses President Trump's plan for the United States to remain the world's leader on artificial intelligence.
Read MoreThe Trade Alliance to Promote Prosperity signed onto a coalition letter urging Congress to pass common sense Pharmacy Benefit Manager (PBM) reforms…
Read MoreThe Trade Alliance to Promote Prosperity is applauding a decision by Bristol Myers Squibb, one of the largest American pharmaceutical innovators, to require the U.K.’s National Health Service to pay its fair share for a newly released schizophrenia treatment, Cobenfy…
Read MoreThe Trade Alliance to Promote Prosperity recently joined a coalition of three dozen organizations in signing a letter to U.S. Secretary of Commerce Howard Lutnick, urging the Trump administration to abandon the idea of imposing a patent tax…
Read MoreThe Trade Alliance to Promote Prosperity recently submitted comments to the Health Resources and Services Administration (HRSA), supporting a proposed 340B rebate pilot program…
Read MoreThe Trade Alliance to Promote Prosperity applauds a new healthcare initiative called “Most Favored Patient” recently launched by the organization Unleash Prosperity Now, which aims to put American patients first and lower healthcare costs…
Read MoreThe Trade Alliance to Promote Prosperity recently joined 10 coalition partners in signing a letter urging President Trump to reject Korea’s discriminatory digital trade practices…
Read More